BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 27256833)

  • 1. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
    Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
    J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
    Bao M; Li H; Li J
    BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
    Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
    Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
    Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study.
    Waleed KB; Tse G; Lu YK; Peng CN; Tu H; Ding LG; Xia YL; Wu SL; Li XT; Zhou HQ; Chen QY; Sun AM; Altaf A; Chang JL; Wang LL
    Rev Cardiovasc Med; 2021 Mar; 22(1):231-238. PubMed ID: 33792267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Plasma Trimethylamine N-Oxide with Coronary Atherosclerotic Burden in Patients with Type 2 Diabetes Among a Chinese North Population.
    Yu N; Gu N; Wang Y; Zhou B; Lu D; Li J; Ma X; Zhang J; Guo X
    Diabetes Metab Syndr Obes; 2022; 15():69-78. PubMed ID: 35035225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity cardiac troponin T level is associated with angiographic complexity of coronary artery disease: a cross-sectional study.
    Yamazaki K; Iijima R; Nakamura M; Sugi K
    Heart Vessels; 2016 Jun; 31(6):890-6. PubMed ID: 25964074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
    Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low diastolic blood pressure is associated with a high atherosclerotic burden in patients with obstructive coronary artery disease.
    Senthong V; Kukongviriyapan U; Settasatian N; Settasatian C; Komanasin N
    Cardiol J; 2018; 25(3):345-352. PubMed ID: 28980283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography.
    Liu X; Xie Z; Sun M; Wang X; Li J; Cui J; Zhang F; Yin L; Huang D; Hou J; Tian J; Yu B
    Int J Cardiol; 2018 Aug; 265():18-23. PubMed ID: 29729869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction.
    Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
    Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
    Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
    Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M
    Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
    Liu Y; Liu S; Zhao Z; Song X; Qu H; Liu H
    Atherosclerosis; 2021 Sep; 333():75-82. PubMed ID: 34438323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Tang WH; Wang Z; Li XS; Fan Y; Li DS; Wu Y; Hazen SL
    Clin Chem; 2017 Jan; 63(1):297-306. PubMed ID: 27864387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary Plaque Characterization Assessed by Optical Coherence Tomography and Plasma Trimethylamine-N-oxide Levels in Patients With Coronary Artery Disease.
    Fu Q; Zhao M; Wang D; Hu H; Guo C; Chen W; Li Q; Zheng L; Chen B
    Am J Cardiol; 2016 Nov; 118(9):1311-1315. PubMed ID: 27600460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.